Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA)

Chronic kidney disease (CKD) is one of the most prevalent and fatal chronic diseases. However, the political attention CKD receives is not proportional to its significant human, economic and ecological burden. One major reason is the lack of awareness among the general population and policymakers. As a result, investment in the therapeutic approaches to CKD have largely remained inadequate, while existing therapies did not change for decades. To respond to the lack of awareness of CKD, several European and international kidney care societies, supported by national and regional organizations, founded the European Kidney Health Alliance (EKHA) in 2007. This Alliance is a Brussels-based advocacy organization representing people with kidney diseases and the kidney care community at the European Union level, and from there, also at the country level. EKHA's aim is to ensure that every candidate for kidney care, irrespective of stage of kidney disease, receives optimal and timely treatment, which is affordable at a societal and individual level. This publication reviews the European political landscape, EKHA's history, points of focus and tools for harnessing available data into advocacy on CKD. Areas discussed include prevention and screening of CKD, its health-economic and environmental impact, and the need to facilitate kidney transplantation and home dialysis. We also examine EKHA's specific approaches to enhance kidney care, its affordability and its sustainability. The EKHA model aims at forestalling the burden of CKD and its underestimated economic and ecologic impact.

Authors

Publication Details

Journal
Universität Zürich, ZORA
Published
2025-03-01
DOI
https://doi.org/10.5167/uzh-283195
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA)

Tom Oostrom, Eveline Scheres, Ilaria de Barbieri, Ole van Vredendaal et al.
Universität Zürich, ZORA
Chronic Kidney Disease and Diabetes
article

Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA)

Tom Oostrom, Eveline Scheres, Ilaria de Barbieri, Ole van Vredendaal, Alicia Bé, Raymond Vanholder, Norbert Lameire, Daniel Gallego, Marine Faure, Valerie A Luyckx
article en

Abstract

Chronic kidney disease (CKD) is one of the most prevalent and fatal chronic diseases. However, the political attention CKD receives is not proportional to its significant human, economic and ecological burden. One major reason is the lack of awareness among the general population and policymakers. As a result, investment in the therapeutic approaches to CKD have largely remained inadequate, while existing therapies did not change for decades. To respond to the lack of awareness of CKD, several European and international kidney care societies, supported by national and regional organizations, founded the European Kidney Health Alliance (EKHA) in 2007. This Alliance is a Brussels-based advocacy organization representing people with kidney diseases and the kidney care community at the European Union level, and from there, also at the country level. EKHA's aim is to ensure that every candidate for kidney care, irrespective of stage of kidney disease, receives optimal and timely treatment, which is affordable at a societal and individual level. This publication reviews the European political landscape, EKHA's history, points of focus and tools for harnessing available data into advocacy on CKD. Areas discussed include prevention and screening of CKD, its health-economic and environmental impact, and the need to facilitate kidney transplantation and home dialysis. We also examine EKHA's specific approaches to enhance kidney care, its affordability and its sustainability. The EKHA model aims at forestalling the burden of CKD and its underestimated economic and ecologic impact.

Universität Zürich, ZORA
Openalex Percentile: Top 27%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.